Raymond James Financial Inc Pacira Bio Sciences, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 13,697 shares of PCRX stock, worth $366,257. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,697
Previous 10,099
35.63%
Holding current value
$366,257
Previous $190,000
78.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$214 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$140 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$60.5 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$59.9 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$54.8 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.23B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...